Impact of Alcohol Misuse on Cognitive and Respiratory Outcomes in COVID-19-associated Acute Respiratory Failure
滥用酒精对 COVID-19 相关急性呼吸衰竭患者认知和呼吸结果的影响
基本信息
- 批准号:10491334
- 负责人:
- 金额:$ 27.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-22 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAcute Respiratory Distress SyndromeAcute respiratory failureAddressAdmission activityAdultAlcohol consumptionAlcoholsAutomobile DrivingBrainCOVID-19COVID-19 pandemicCOVID-19 patientCOVID-19 survivorsCOVID-19/ARDSCharacteristicsClinicCognitionCognitiveColoradoConsumptionConvalescenceCoronavirusCritical IllnessDataDeliriumDevelopmentDiagnosisEnrollmentFunctional disorderFundingGoalsHealthHealth systemHigh PrevalenceHospitalizationHospitalsHypoxemic Respiratory FailureImpaired cognitionImpairmentInfectionIntensive Care UnitsInterventionInvestigationLungMechanical VentilatorsMechanical ventilationMental HealthMonoclonal Antibody R24Morbidity - disease rateNational Institute on Alcohol Abuse and AlcoholismNeurocognitiveOutcomePatientsPost-Acute Sequelae of SARS-CoV-2 InfectionPredispositionRecording of previous eventsRecoveryReportingResearchResidual stateResourcesRespiration DisordersRespiratory FailureRespiratory physiologyRetrospective cohortRiskRisk FactorsRoleServicesSeveritiesSeverity of illnessSubgroupSurvivorsUniversitiesWaxesWorkalcohol misusealcohol researchbrain dysfunctioncohorthealth assessmentimprovedlung developmentlung injurymental statemortalitymultidisciplinarypandemic diseaseprospectivepulmonary functionrespiratoryrespiratory healthresponse
项目摘要
Project Summary/Abstract
During the Coronavirus (COVID)-19 pandemic, the number of patients diagnosed with the acute respiratory
distress syndrome (ARDS) has increased dramatically in the US. COVID-19-associated ARDS is characterized
by high morbidity, including a requirement for protracted mechanical ventilator support. In a substantial
percentage of patients who survive hospitalization, deficits including neurocognitive dysfunction and residual
pulmonary impairment have been reported as so-called Post-Acute Sequelae of COVID-19 (PASC). Therefore,
it is imperative to urgently establish addressable factors that drive poor outcomes. Prior to the COVID-19
pandemic, investigations by our research group demonstrated that alcohol misuse is associated with an
increased severity of ARDS, which may contribute to residual pulmonary dysfunction in survivors. Alcohol
misuse can also propagate development of delirium that may increase risk for cognitive impairment in
recovery. Notably, delirium has been reported in half of all COVID-19 patients in the ICU, and alcohol misuse
appears to increase odds for its development. Although reports of increasing alcohol misuse during the
pandemic are widespread and might be one modifiable factor driving severity of illness and outcomes, its
impact on the trajectory of illness in COVID-19 has not been fully evaluated. The goal of this proposal is to
determine if alcohol misuse promotes ICU delirium that in turn increases requirements for mechanical
ventilation among patients with COVID-19-associated ARDS. Also, we wish to establish if alcohol misuse
contributes to persistent cognitive and respiratory PASC in COVID-19 survivors. To address these questions,
two aims are proposed. Aim 1: In hospitalized patients with COVID-19-associated ARDS, determine if alcohol
misuse is associated with increased mechanical ventilation requirements, and if delirium further influences this
relationship. Investigations will be conducted in a prospectively enrolled cohort of patients with COVID-19-
associated ARDS, who are in the ICU at the University of Colorado Hospital (Aim 1a), and in a retrospective
cohort of hospitalized patients with COVID-19, previously admitted in the University of Colorado Health system
(Aim 1b). Aim 2: Among patients recovering from COVID-19, determine the impact of alcohol misuse on
cognition and respiratory function in recovery, accounting for characteristics of acute illness that include
requirements for mechanical ventilation and ICU delirium. Investigations will be conducted in patients followed
in a multidisciplinary COVID-19 Recovery Clinic, who will have cognitive, mental, and respiratory health
evaluated over the year following hospital discharge. Our proposed research will help determine if patients with
alcohol misuse warrant targeted strategies to identify and treat delirium in the setting of COVID-19-associated
respiratory failure, and it will clarify if hospitalized patients with COVID-19 and alcohol misuse represent a
unique subgroup at risk for PASC who may merit specific services or interventions.
项目摘要/摘要
在冠状病毒(Covid)-19大流行期间,被诊断为急性呼吸道的患者人数
在美国,遇险综合征(ARDS)急剧增加。 COVID-19相关的ARD的表征
通过高发病率,包括对持久的机械呼吸机的支撑。实质性
存活住院的患者百分比,包括神经认知功能障碍和残留的患者百分比
据报道,肺部受损是Covid-19(PASC)的所谓急性后遗症。所以,
必须紧急建立可寻求不良结果的可寻址因素。在19号之前
大流行,我们的研究小组的调查表明,滥用酒精与
ARDS的严重程度增加,这可能导致幸存者中残留的肺部功能障碍。酒精
滥用还可以传播ir妄的发展,这可能会增加认知障碍的风险
恢复。值得注意的是,在ICU中的所有Covid-19患者中,del妄已有一半,滥用酒精
似乎增加了其发展的赔率。尽管在此期间有滥用酒精的报道
大流行是普遍的
尚未完全评估COVID-19中对疾病轨迹的影响。该提议的目的是
确定滥用酒精是否促进了ICU del妄,进而增加了机械的要求
共同19-19相关的ARDS患者的通风。另外,我们希望确定是否滥用酒精
有助于19009幸存者的持续认知和呼吸道PASC。要解决这些问题,
提出了两个目标。 AIM 1:在与19009年相关ARDS的住院治疗患者中,确定是否酒精
滥用与增加机械通气要求有关,如果del妄进一步影响这一点
关系。将在前瞻性招收的COVID-19-患者队列中进行调查。
在科罗拉多大学医院(AIM 1A)的ICU和回顾性的ARDS
先前在科罗拉多大学卫生系统中录取的Covid-19患者的同类
(AIM 1B)。 AIM 2:在从Covid-19的患者中,确定滥用酒精的影响
恢复中的认知和呼吸功能,考虑到包括急性疾病的特征
机械通气和ICU del妄的要求。随后将对患者进行调查
在多学科的Covid-19恢复诊所中,他们将具有认知,心理和呼吸健康
出院后的一年中进行了评估。我们提出的研究将有助于确定患者是否
滥用酒精的有针对性的策略,以识别和治疗del妄,以期为19次相关
呼吸衰竭,它将澄清住院的19. Covid-19和滥用酗酒的患者
对PASC的风险独特的子组,可能需要特定的服务或干预措施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELLEN L BURNHAM其他文献
ELLEN L BURNHAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELLEN L BURNHAM', 18)}}的其他基金
Impact of Dual Alcohol and Cannabis Use on Lung
双重酒精和大麻使用对肺的影响
- 批准号:
10302164 - 财政年份:2021
- 资助金额:
$ 27.33万 - 项目类别:
Impact of Alcohol Misuse on Cognitive and Respiratory Outcomes in COVID-19-associated Acute Respiratory Failure
滥用酒精对 COVID-19 相关急性呼吸衰竭患者认知和呼吸结果的影响
- 批准号:
10391807 - 财政年份:2021
- 资助金额:
$ 27.33万 - 项目类别:
Impact of Dual Alcohol and Cannabis Use on Lung
双重酒精和大麻使用对肺的影响
- 批准号:
10471332 - 财政年份:2021
- 资助金额:
$ 27.33万 - 项目类别:
Impact of Alcohol Misuse on Cognitive and Respiratory Outcomes in COVID-19-associated Acute Respiratory Failure
滥用酒精对 COVID-19 相关急性呼吸衰竭患者认知和呼吸结果的影响
- 批准号:
10671588 - 财政年份:2021
- 资助金额:
$ 27.33万 - 项目类别:
Celiac disease signatures in Down syndrome (KL2 Admin Suppl)
唐氏综合症的乳糜泻特征(KL2 Admin Suppl)
- 批准号:
10117961 - 财政年份:2018
- 资助金额:
$ 27.33万 - 项目类别:
Clinical Resource for Lung and Alcohol Investigations
肺和酒精研究的临床资源
- 批准号:
8078579 - 财政年份:2011
- 资助金额:
$ 27.33万 - 项目类别:
CoPARC: Colorado Pulmonary Alcohol Research Collaborative
CoPARC:科罗拉多州肺酒精研究合作组织
- 批准号:
9926794 - 财政年份:2011
- 资助金额:
$ 27.33万 - 项目类别:
相似国自然基金
锌离子转运蛋白SLC39A1在急性呼吸窘迫综合征中的作用和机制
- 批准号:32371177
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
蜗牛粘液糖胺聚糖影响中性粒细胞粘附和迁移在治疗急性呼吸窘迫综合征中的作用研究
- 批准号:82360025
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
β-catenin诱导调节性T细胞代谢重编程及亚型转化在急性呼吸窘迫综合征的作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
特络细胞源性外泌体经JAK/STAT-miRNA-E2F轴修复肺血管改善急性呼吸窘迫综合征的机制研究
- 批准号:82272230
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
相似海外基金
The Intermountain West-Atlantic Center (InterACT) for the APS Phenotyping Consortium
APS 表型联盟的山间西大西洋中心 (InterACT)
- 批准号:
10649343 - 财政年份:2023
- 资助金额:
$ 27.33万 - 项目类别:
Identifying patient subgroups and processes of care that cause outcome differences following ICU vs. ward triage among patients with acute respiratory failure and sepsis
确定急性呼吸衰竭和脓毒症患者在 ICU 与病房分诊后导致结局差异的患者亚组和护理流程
- 批准号:
10734357 - 财政年份:2023
- 资助金额:
$ 27.33万 - 项目类别:
Development of a Neutrophil Degranulation Inhibitor to Treat ARDS
开发治疗 ARDS 的中性粒细胞脱颗粒抑制剂
- 批准号:
10697442 - 财政年份:2023
- 资助金额:
$ 27.33万 - 项目类别:
Restoring Endothelial Function After Traumatic Injury to Reduce ARDS and Multi-Organ Dysfunction
创伤性损伤后恢复内皮功能以减少 ARDS 和多器官功能障碍
- 批准号:
10739123 - 财政年份:2023
- 资助金额:
$ 27.33万 - 项目类别:
Novel Markers of Treatment Responsiveness for Pediatric Acute Asthma Exacerbations
小儿哮喘急性加重治疗反应性的新标志物
- 批准号:
10850297 - 财政年份:2022
- 资助金额:
$ 27.33万 - 项目类别: